Literature DB >> 9683525

Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.

Y Arita1, P Buffolino, D L Coppock.   

Abstract

12-O-Tetradecanoyl phorbol-13-acetate (TPA) inhibits the growth of most malignant melanoma cells but stimulates the growth of normal human melanocytes. We previously showed that addition of TPA inhibits the growth of the human metastatic melanoma cell line, Demel, by blocking cells at both the G1/S and G2/M cell cycle transitions (D. L. Coppock et al., 1992, Cell Growth Differ. 3, 485-494). To examine the G2/M transition, we developed a method to synchronize the cells in early S phase using Lovastatin and mevalonate, followed by treatment with hydroxyurea (HU). TPA (30 nM) was effective in blocking cells from entering mitosis and reentering G1 when added up to the end of G2. These cells arrested in G2. Examination of the levels of cyclins A and B1 demonstrated that the levels of these cyclins were not limiting for entrance into M. However, the addition of TPA blocked the increase in p34(cdc2)/cyclin B1 kinase activity. In cells treated with TPA, most p34(cdc2) was found in the slowly migrating forms on Western blots, which contained increased levels of phosphotyrosine. In addition, the level of the cyclin-dependent kinase inhibitor p21(Cip1/Waf1), but not of p27(Kip1), was increased. We examined the expression of protein kinase C (PKC) isoforms in Demel cells using Western blots to understand which types were involved in the G2 arrest. Demel cells expressed the PKC alpha, betaI, betaII, delta, epsilon, iota/lambda, zeta, and mu isozymes. PKC eta and PKC theta were not detected. Addition of TPA did not completely down regulate any PKC isozymes over a 12-h period in these synchronized cells. PKC alpha, betaI, betaII, delta, and epsilon isozymes were translocated to the membrane fraction from the cytosolic fraction when treated with TPA. PKC delta appeared as a doublet and the addition of TPA shifted a majority to the slower migrating form. The level of PKC mu was constant; however, a slow mobility form was observed in TPA-treated cells. This reduced mobility was at least partially due to phosphorylation. Thus, the arrest of growth in G2 appears to be due to the inhibition of the p34(cdc2) kinase activity which is associated with the increased expression of p21(Cip1/Waf1) and increased phosphorylation on tyrosine of p34(cdc2). This arrest, in turn, is associated with a shift of PKC isozymes PKC alpha, PKC betaI, PKC betaII, PKC delta, PKC epsilon, and PKC mu to the membrane fraction which is induced by addition of TPA. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683525     DOI: 10.1006/excr.1997.3911

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression.

Authors:  A Besson; V W Yong
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  Protein kinase C mediates phosphorylation of the regulatory light chain of myosin-II during mitosis.

Authors:  O Varlamova; A Spektor; A R Bresnick
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

3.  Protein kinase D isozymes activation and localization during mitosis.

Authors:  Romeo Papazyan; Michael Doche; Richard T Waldron; Enrique Rozengurt; Mary Pat Moyer; Osvaldo Rey
Journal:  Exp Cell Res       Date:  2008-07-26       Impact factor: 3.905

4.  PMA synergistically enhances apicularen A-induced cytotoxicity by disrupting microtubule networks in HeLa cells.

Authors:  Kang-Sik Seo; Jong-Seok Kim; Ji-Hoon Park; Kyoung-Sub Song; Eun-Jin Yun; Jong-Il Park; Gi Ryang Kweon; Wan-Hee Yoon; Kyu Lim; Byung-Doo Hwang
Journal:  BMC Cancer       Date:  2014-01-22       Impact factor: 4.430

5.  BRAFV600E induces reversible mitotic arrest in human melanocytes via microrna-mediated suppression of AURKB.

Authors:  Andrew S McNeal; Rachel L Belote; Hanlin Zeng; Marcus Urquijo; Kendra Barker; Rodrigo Torres; Meghan Curtin; A Hunter Shain; Robert Hi Andtbacka; Sheri Holmen; David H Lum; Timothy H McCalmont; Matt W VanBrocklin; Douglas Grossman; Maria L Wei; Ursula E Lang; Robert L Judson-Torres
Journal:  Elife       Date:  2021-11-23       Impact factor: 8.140

6.  PKC alpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1.

Authors:  Qianying Gao; Juan Tan; Ping Ma; Jian Ge; Yaqin Liu; Xuerong Sun; Lian Zhou
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.